End-inspiratory pause prolongation in acute respiratory distress syndrome patients: effects on gas exchange and mechanics by Hernan Aguirre-Bermeo et al.
Aguirre‑Bermeo et al. Ann. Intensive Care  (2016) 6:81 
DOI 10.1186/s13613‑016‑0183‑z
RESEARCH
End‑inspiratory pause prolongation 
in acute respiratory distress syndrome patients: 
effects on gas exchange and mechanics
Hernan Aguirre‑Bermeo1, Indalecio Morán1, Maurizio Bottiroli2, Stefano Italiano1, Francisco José Parrilla1, 
Eugenia Plazolles1, Ferran Roche‑Campo3 and Jordi Mancebo1*
Abstract 
Background: End‑inspiratory pause (EIP) prolongation decreases dead space‑to‑tidal volume ratio (Vd/Vt) and 
PaCO2. We do not know the physiological benefits of this approach to improve respiratory system mechanics in acute 
respiratory distress syndrome (ARDS) patients when mild hypercapnia is of no concern.
Methods: The investigation was conducted in an intensive care unit of a university hospital, and 13 ARDS patients 
were included. The study was designed in three phases. First phase, baseline measurements were taken. Second 
phase, the EIP was prolonged until one of the following was achieved: (1) EIP of 0.7 s; (2) intrinsic positive end‑
expiratory pressure ≥1 cmH2O; or (3) inspiratory–expiratory ratio 1:1. Third phase, the Vt was decreased (30 mL every 
30 min) until PaCO2 equal to baseline was reached. FiO2, PEEP, airflow and respiratory rate were kept constant.
Results: EIP was prolonged from 0.12 ± 0.04 to 0.7 s in all patients. This decreased the Vd/Vt and PaCO2 (0.70 ± 0.07 
to 0.64 ± 0.08, p < 0.001 and 54 ± 9 to 50 ± 8 mmHg, p = 0.001, respectively). In the third phase, the decrease in Vt 
(from 6.3 ± 0.8 to 5.6 ± 0.8 mL/Kg PBW, p < 0.001) allowed to decrease plateau pressure and driving pressure (24 ± 3 
to 22 ± 3 cmH2O, p < 0.001 and 13.4 ± 3.6 to 10.9 ± 3.1 cmH2O, p < 0.001, respectively) and increased respiratory 
system compliance from 29 ± 9 to 32 ± 11 mL/cmH2O (p = 0.001). PaO2 did not significantly change.
Conclusions: Prolonging EIP allowed a significant decrease in Vt without changes in PaCO2 in passively venti‑
lated ARDS patients. This produced a significant decrease in plateau pressure and driving pressure and significantly 
increased respiratory system compliance, which suggests less overdistension and less dynamic strain.
Keywords: End‑inspiratory pause, Dead space, Tidal volume, Acute respiratory distress syndrome, Mechanical 
ventilation
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Mechanical ventilation in patients with acute respira-
tory distress syndrome (ARDS) must combine both low 
tidal volumes (Vt) and adequate positive end-expiratory 
pressure (PEEP) [1, 2]. However, in patients with ARDS, 
respiratory acidosis and high airway plateau pressures 
(Pplat) may limit management of ventilatory adjustments. 
In particular, the functional consequences of hypercapnia 
and respiratory acidosis may differ considerably depend-
ing on a patient’s condition, and they may involve almost 
any physiological function [3–6].
Optimization of mechanical ventilation parameters is 
associated with a reduction in dead space and is a use-
ful strategy to reduce hypercapnia in ARDS patients 
[7]. Many other strategies have also been developed to 
decrease hypercapnia at the bedside, such as increases in 
respiratory rate [8], use of active humidifiers [9] and the 
tracheal gas insufflation [10] or aspiration of dead space 
[11]. At bedside, the dead space could be calculated using 
the Enghoff modification of the Bohr equation. The use 
of this equation implies the use of PaCO2 as surrogate for 
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alveolar carbon dioxide. Therefore, this equation meas-
ures a global index of efficiency of gas exchange because 
it takes also shunt effect into account [12].
Some authors have also shown that prolonging the 
end-inspiratory pause (EIP) is a feasible maneuver to 
achieve similar targets [13, 14]. In experimental models 
[15] and in ARDS patients [14, 16–18], EIP prolongation 
has proven effective at enhancing CO2 elimination and 
decreasing partial pressure of carbon dioxide in arte-
rial blood (PaCO2) and also physiological dead space 
(Vdphys). Prolonging EIP extends the time available for an 
enhanced diffusion between inhaled Vt and resident alve-
olar gas, thus facilitating the transfer of CO2 from alveoli 
toward the airways [17, 18].
Although several of the physiological studies described 
above have reported that EIP prolongation improves gas 
exchange, none have investigated the potential physi-
ological benefits of this approach in terms of Vt reduc-
tion or improved respiratory system mechanics when 
hypercapnia is of no concern. To address this gap, the 
objective of our study was to ascertain whether EIP pro-
longation decreases PaCO2 and whether this effect can 
be used to decrease Vt while keeping PaCO2 constant. 
We hypothesized that this approach may have benefi-
cial effects on respiratory system mechanics in ARDS 
patients.
Methods
The study was performed in the Intensive Care Unit at 
Hospital de la Santa Creu i Sant Pau, Barcelona (Spain). 
The institutional ethics committee approved the study 
(Reference: 10/089), and the patients’ relatives gave 
signed informed consent.
Patients
Fourteen patients who met the criteria for ARDS [19] 
were included in the study. Exclusion criteria were: age 
<18 years, pregnancy, hemodynamic or respiratory insta-
bility, and variation of more than 0.5 °C in body tempera-
ture in the last 12  h before the study was planned [20]. 
One patient was excluded during the study period (see 
Results).
All patients were under sedation and analgesia with 
intravenous perfusion of midazolam and opiates. Neu-
romuscular blockade was used in all patients to prevent 
triggering of the ventilator. Careful endotracheal suc-
tioning was performed before the protocol was started. 
Heated humidifiers (Fisher & Paykel; MR 290 chamber 
and MR 850 ALU electric heater; Panmure, New Zea-
land) were used for airway humidification in all patients. 
These humidifiers were placed in the inspiratory limb of 
the circuit in accordance with the manufacturer’s recom-
mendations. The respiratory rate, FiO2, inspiratory flow 
(square pattern) and PEEP were kept constant through-
out the study.
Protocol
All patients were in steady state in the 60-min preceding 
data recording, and all of them were in a semirecumbent 
position. The study was performed in three consecutive 
30-min phases. Measurements in the first phase (base-
line phase) were taken under the mechanical ventilation 
parameters set by the patient’s attending physician. In the 
second phase (EIP prolongation phase), the EIP was pro-
longed until one of the following parameters was reached: 
(1) EIP of 0.7 s; (2) intrinsic positive end-expiratory pres-
sure (PEEPi) ≥1  cmH2O; or (3) inspiratory–expiratory 
ratio (I/E) of 1:1. We chose the EIP prolongation time 
(0.7 s) based on findings from a previous study by Deva-
quet et al. [18] in which a 20 % prolongation of the inspir-
atory time induced a significant decrease in PaCO2 and 
dead space. In the third phase (Vt reduction phase), the 
Vt was diminished in steps of 30 mL every 30 min until 
PaCO2 reached baseline levels.
The following data were collected at inclusion: demo-
graphic variables (age, sex, height), simplified acute phys-
iology score II, ARDS etiology and days of mechanical 
ventilation.
During the last minute of each phase, we collected the 
following respiratory variables: peak airway pressure, 
Pplat, mean airway pressure, PEEPi, PEEP, driving air-
way pressure (∆Paw), Vt, dead space-to-Vt ratio (Vd/Vt), 
static compliance of the respiratory system (Crs) and air-
way resistance. At the same time, we recorded the follow-
ing gas exchange variables: pH, partial pressure of arterial 
oxygen (PaO2), PaCO2 and end-tidal carbon dioxide con-
centration in the mixed expired gas (EtCO2). PEEPi was 
measured with a prolonged end-expiratory pause of 4 s, 
performed using the ventilator expiratory hold button. 
EtCO2 was measured continuously with a CO2 main-
stream sensor (General Electric Capnostat, Milwaukee, 
WI, USA). The mean value of the last 10 recorded EtCO2 
values in each phase of the study was used for analysis.
Ventilatory settings and airway pressures were 
recorded directly from the ventilator monitoring sys-
tem. Plateau pressure was measured during an end-
inspiratory pause. Dead space was calculated using the 
Enghoff modification of the Bohr equation [21]: Vd/
Vt  =  (PaCO2  −  PeCO2)/PaCO2, being PeCO2 the par-
tial pressure of carbon dioxide in mixed expired gas. 
Expired gas was measured by collecting gas for 3  min 
with a Douglas bag (P-341–60; Warren E. Collins Inc., 
Boston, MA, USA) attached directly to the expiratory 
port of the ventilator. An automated analyzer (ABL 520; 
Radiometer A/S, Copenhagen, Denmark) was used to 
measure expired and arterial gases. Dead space data 
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were expressed as physiological dead space (Vdphys in 
mL), defined as the sum of instrumental, anatomic and 
alveolar dead space [22]. Driving pressure (cmH2O) 
was calculated as Pplat-PEEP. Crs (mL/cmH2O) was 
calculated as Vt/[Pplat-(PEEP  +  PEEPi)], and airway 
resistance (cmH2O/L/s) was calculated as (peak air-
way pressure  −  plateau pressure)/Flow. Predicted body 
weight (PBW) was calculated as follows: 50 + 0.91(height 
in cm-152.4) for men and 45.5 + 0.91(height in cm-152.4) 
for women [8]. Arterial to end-tidal CO2 gradient (P(a-et)
CO2) was calculated in each study phase. We used Puri-
tan Bennett™ 840 (Covidien, Galway, Ireland) and Dräger 
Evita XL (Dräger Medical, Lübeck, Germany) ventilators. 
All the ventilators used have a compressible volume com-
pensation system.
Statistical analysis
Data are expressed as mean  ±  standard deviation. The 
results were analyzed using one-way analysis of variance 
for repeated measures (ANOVA) with the Greenhouse–
Geisser correction. We performed the Kolmogorov–
Smirnov test to confirm normal data distribution. Since 
the distribution of the data was normal, we used the Stu-
dent’s t test and the Pearson linear correlation to com-
pare data and correlations between phases and variables, 
respectively. A two-tailed p value less than 0.05 was con-
sidered statistically significant. The SPSS® Statistics (ver-
sion 20.0, Chicago, IL, USA) statistical software was used 
for statistical analysis.
Results
One of the 14 patients enrolled in the study was excluded 
from the analysis due to fever, tachypnea and unstable 
EtCO2 during the second phase of the study. The study 
was performed 5 ± 4 days after starting mechanical ven-
tilation. Table  1 shows demographic data at admission, 
ARDS etiology and baseline characteristics at study day.
Baseline EIP was 0.12  ±  0.04  s, and it was increased 
to 0.7 ±  0  s in all patients (p  <  0.001). This EIP change 
was performed maintaining PEEPi <1 cmH2O (0.2 ± 0.2 
to 0.5  ±  0.4  cmH2O, p  =  0.06) and without the I/E 
inverse ratio ventilation (1:4.7  ±  0:1.3 to 1:1.7  ±  0:0.4, 
p  =  <0.001). EIP prolongation decreased Vdphys and 
PaCO2 significantly with respect to basal conditions 
(267 ± 71 to 244 ± 65 mL and 54 ± 9 to 50 ± 8 mmHg, 
respectively; p  <  0.001 for both comparisons). The 
decrease in PaCO2 levels due to EIP prolongation was 
correlated with the drop in Vdphys (r = 0.871; p < 0.001). 
Individual changes in PaCO2 and in Vdphys are shown in 
Figs. 1 and 2, respectively.
Between the first and second phase, significant 
decreases were observed in both the Vd/Vt ratio 
(0.70 ± 0.07 to 0.64 ± 0.08; p < 0.001) and EtCO2 (41 ± 6 
to 39  ±  6  mmHg; p  =  0.006). Basal Vdphys and P(a-et)
CO2 had a close correlation (r  =  0.75; p  =  0.003). The 
change in Vdphys and the change in P(a-et)CO2 between 
the first and second phase also showed a close correlation 
(r = 0.68; p = 0.001).
In the third phase (EIP prolongation and Vt reduction), 
the Vt was significantly reduced as compared to previous 
phases (6.3 ±  0.8 to 5.6 ±  0.8 mL/Kg PBW; p < 0.001). 
In the third phase, as per protocol design, the PaCO2 and 
pH values were statistically identical to those at baseline 
(54 ± 9 vs. 54 ± 10 mmHg; p = 0.90 and 7.31 ± 0.07 vs. 
7.31 ± 0.08; p = 0.90, respectively).
The Vdphys decreased progressively and significantly 
during all phases of the study (267 ±  71 to 244 ±  65 to 
216 ± 58 mL; p < 0.001). The Vdphys and Vt at baseline were 
strongly correlated (r = 0.946; p < 0.001). Additionally, the 
Vt reduction was tightly correlated with the decrease in 
Vdphys (r = 0.894; p < 0.001). Respiratory system mechan-
ics, gas exchange, hemodynamics, and temperature data 
throughout the study are also given in Table 2.
Discussion
The main finding of our study was that the end-inspira-
tory pause prolongation allowed to decrease tidal vol-
ume while maintaining similar PaCO2 levels. Indeed, the 
decrease in tidal volume led to a significant decrease in 
Pplat and ∆Paw, and it also improved the respiratory sys-
tem compliance.
Several studies have shown that prolongation of EIP 
enhances CO2 elimination and decreases dead space and 
PaCO2 levels [14–18]. Diffusion of CO2 is time depend-
ent, and EIP prolongation increases the time available for 
alveolar gas exchange [14, 23, 24]. Devaquet et  al. [18] 
extended inspiratory time from 0.7 ± 0.2 to 1.4 ± 0.3 s by 
increasing the inspiratory pause time from 0 to 20 % of 
the total breathing cycle. They observed that this modifi-
cation significantly decreased both Vd/Vt (around 10 %) 
and PaCO2 (around 11 %). Despite these beneficial effects 
of prolonged EIP and the direct relationship between 
inspiratory time and enhanced CO2 elimination [16, 18], 
EIP prolongation may lead to potentially adverse effects 
such as PEEPi production and inversion of the I/E ratio 
together with increases in mean airway pressure. These 
effects might also provoke hyperinflation, thus altering 
cardiac performance [25, 26]. Nevertheless, Devaquet 
and colleagues [18] showed that EIP could be prolonged 
without significantly increasing PEEPi (I/E ratio 1:1.5). 
Not surprisingly, and in spite of a significant increase in 
EIP, we did not induce any significant increase in PEEPi 
since the expiratory time was long enough to avoid air 
trapping at the end of a passive expiration (average expir-
atory time 1.7 ± 0.3  s). Actually (see Table 2), the aver-
age product of three time constants (the time needed to 
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passively exhale 96 % of inhaled tidal volume) was in our 
patients about 1.1 s. (0.373 × 3 = 1.1 s), well below to the 
average expiratory time.
Prolongation of EIP in our patients caused a signifi-
cant decrease in dead space and PaCO2 levels that was 
similar to previously reported [14–18]. When comparing 
phase 1 (baseline) and phase 2 (isolated EIP prolonga-
tion), we found that the decrease in the Vd/Vt correlated 
well with the drop in PaCO2 (r = 0.810; p < 0.001). These 
changes observed in our patients may be explained by the 
increase on the time available for distribution and dif-
fusion of inspired tidal gas within resident alveolar gas 
during EIP prolongation [14]. Indeed, total PEEP levels, 
airflow, respiratory rate, tidal volume and respiratory 
mechanics were totally unchanged in this phase of our 
study [14, 27, 28].
Comparing the second (isolated EIP prolongation) and 
third (EIP prolongation and Vt reduction) phases, our 
data showed that the Vd/Vt ratio remained unchanged. 
However, the Vdphys, expressed in mL, decreased signifi-
cantly between phases 2 and 3. This is explained by the 
significant reduction in Vt (that also provoked a decrease 
in Vdphys) during the third phase as compared to the 
previous phases, and thus Vd/Vt ratio did not change. 
The fact that the reduction in Vt in the third phase was 
accompanied by a significant decrease in Vdphys and 
ΔPaw (with a significant increase in compliance) suggests 
that some degree of overdistension might be present at 
baseline.
As previously described, low tidal volume ventilation in 
ARDS may induce hypercapnia and, secondarily, induce 
pulmonary artery hypertension that may impair right 
ventricular function [29] and eventually cause acute cor 
pulmonale [30]. To reduce hypercapnia in ARDS venti-
lated patients, active heated humidifiers are often used. 
These devices significantly decrease dead space, PaCO2 
and ventilator mechanical load [9] without increasing 
airflow resistance [31]. Although active humidification 
is recommended over heat and moisture exchangers in 
ARDS patients [32], two studies focussing on the effects 
of EIP prolongation on gas exchange [16, 17] did not 
describe the type of humidification used in their patients. 
A third study used passive or active humidification (10 
and 5 patients, respectively) [18]. However, the effects 
on PaCO2 in all these studies [16–18] were consistently 
the same, thus suggesting that humidification type per se 
does not influence the effects of EIP on PaCO2.
Another technique used to decrease hypercapnia is to 
increase the respiratory rate. However, in ARDS patients, 
several studies have shown that a high respiratory rate led 
to gas trapping and induced PEEPi [33, 34]. In addition, 
experimental models suggested that higher respiratory 
rates may contribute to the development of ventilator-
induced lung injury [35, 36]. Vieillard-Baron et  al. [25] 
compared two respiratory rate strategies, 30 versus 
15  breaths/min. They found that the high respiratory 
rate did not reduce PaCO2 levels but produced dynamic 
hyperinflation and reduced the cardiac index. In our 
patients, EIP prolongation was achieved with a relatively 
Fig. 1 Individual values for PaCO2 during the study. The asterisk 
denotes statistically significant differences (p < 0.001) during pro‑
longation of end‑inspiratory pause. EIP end‑inspiratory pause, PaCO2 
partial pressure of carbon dioxide in arterial blood, Vt tidal volume
Fig. 2 Individual values for Vdphys during the study. The asterisks 
denote a significant, progressive decrease in Vd phys (p < 0.001) during 
prolongation of end‑inspiratory pause (EIP) and during Vt reduction. 
EIP end‑inspiratory pause, Vdphys physiological dead space, Vt tidal 
volume
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high inspiratory flow rate (1  L/s), thus avoiding inverse 
I/E ratio. This was a safe strategy to decrease PaCO2 lev-
els, while keeping respiratory rate constant (22 breaths/
min) and not generating PEEPi.
In our study, the reduction in Vt to maintain isocap-
nia was modest. Should major reductions in Vt were 
required, then the use of invasive extracorporeal carbon 
dioxide removal devices had to be considered in order to 
avoid acute hypercapnia [37].
Studies analyzing the EIP prolongation did not describe 
changes in PaO2 [14, 18], except one study by Mercat 
et al. [16]. This latter study found a slight, but not statisti-
cally significant, increase in PaO2 levels during EIP pro-
longation. This finding was not confirmed in our study. 
We speculate that the length of time that patients are 
maintained with EIP prolongation and the mean airway 
pressure achieved during extended EIP may have con-
tributed to this finding. Indeed, in Mercat’s study [16], 
EIP prolongation was continued for 1 h with a mean air-
way pressure of 21 cmH2O and an I/E ratio 1.1. In con-
trast, in Devaquet’s study [18] and in our own study, EIP 
prolongation was shorter (30 min in both), mean airway 
pressure was lower (15 and 17 cmH2O, respectively), and 
the I/E ratios achieved were 1:1.5 in Devaquet’s study and 
1:1.7 in ours.
The main novelty of our study is that prolonging 
EIP allowed to reduce Vt by 11  % (from 6.3  ±  0.8 to 
5.6 ± 0.8 mL/kg of PBW; p < 0.001), maintaining PaCO2 
levels equal to baseline. These sequential ventilatory 
changes were accompanied by a reduction in Vdphys. 
Also, when PaCO2 returned to baseline due to a reduc-
tion in Vt, we found a significant decrease in Pplat and an 
increase in Crs. In addition, these changes in ventilatory 
mechanics were accompanied by a significant decrease in 
∆Paw. All those findings could be explained by a degree 
of baseline overinflation even though our initial Vt was 
low [38]. We further support our contention by the tight 
correlation between Vt and Vdphys at the onset of the 
study and the tight correlation between the decrease in 
Vt and Vdphys at the end of the study. Our patients were 
basally ventilated with parameters similar to those used 
in previous studies [16–18] in terms of Vt and PEEP, and 
Table 2 Respiratory system mechanics, gas exchange and hemodynamic data during the study
Data are presented as number (%) or mean ± SD
Intergroup differences (p < 0.05): a, phase 1 versus phase 2; b, phase 1 versus phase 3; c, phase 2 versus phase 3
Crs static compliance of the respiratory system, EIP end‑inspiratory pause, EtCO2 end‑tidal carbon dioxide concentration in the expired air, FiO2 fraction of inspired 
oxygen, HR heart rate, MAP mean arterial pressure, PaO2 partial pressure of oxygen in arterial blood, PaCO2 partial pressure of carbon dioxide in arterial blood, PBW 
predicted body weight, PEEPi intrinsic positive end‑expiratory pressure, Pmean mean airway pressure, Ppeak peak airway pressure, Pplat plateau airway pressure, 
P(a‑et)CO2 arterial to end‑tidal CO2 gradient, Raw airway resistance, Vdphys physiological dead space, Vd/Vt dead space‑to‑Vt ratio, Vt tidal volume, ∆Paw driving airway 
pressure
Phase 1  
(baseline)
Phase 2  
(EIP prolongation)






EIP (s) 0.12 ± 0.04 0.7 ± 0 0.7 ± 0 <0.001 a, b
Ppeak (cmH2O) 38 ± 6 38 ± 6 35 ± 5 <0.001 b, c
Pmean (cmH2O) 15 ± 3 18 ± 2 17 ± 2 <0.001 a, b, c
Pplat (cmH2O) 24 ± 3 24 ± 3 22 ± 3 <0.001 b, c
PEEPi (cmH2O) 0.2 ± 0.2 0.5 ± 0.4 0.5 ± 0.4 0.06
Vt (mL) 378 ± 73 378 ± 73 336 ± 61 <0.001 b, c
Vt (PBW; mL/Kg) 6.3 ± 0.8 6.3 ± 0.8 5.6 ± 0.8 <0.001 b, c
Vdphys (mL) 267 ± 71 244 ± 65 216 ± 58 <0.001 a, b, c
Vd/Vt 0.70 ± 0.07 0.64 ± 0.08 0.64 ± 0.08 <0.001 a, b
Crs (mL/cmH2O) 29 ± 9 29 ± 9 32 ± 11 0.001 b, c
∆ Paw (cmH2O) 13.6 ± 3.6 13.4 ± 3.6 10.9 ± 3.1 <0.001 a, b, c
Raw (cmH2O/L/s) 14 ± 5 13 ± 5 13 ± 4 0.28
pH 7.31 ± 0.07 7.34 ± 0.09 7.31 ± 0.08 <0.001 a, c
PaO2 (mmHg) 102 ± 23 98 ± 23 105 ± 29 0.35
PaCO2 (mmHg) 54 ± 9 50 ± 8 54 ± 10 <0.001 a, c
EtCO2 (mmHg) 41 ± 6 39 ± 6 43 ± 7 0.002 a, c
P(a‑et)CO2 (mmHg) 13 ± 6 12 ± 8 12 ± 9 0.27
MAP (mmHg) 80 ± 12 76 ± 9 77 ± 12 0.08
HR (beats/min) 87 ± 19 83 ± 20 86 ± 21 0.14
Temperature (°C) 36.7 ± 0.9 36.7 ± 0.9 36.6 ± 0.8 0.61
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Vd/Vt was also similar. Moreover, in our patients, Crs 
was lower (29 mL/cmH2O) than in Mercat and Devaquet 
studies (37 and 50  mL/cmH2O, respectively). Our find-
ings thus suggest that if PaCO2 is clinically tolerable, EIP 
prolongation in ARDS provides physiological benefits 
including a small and consistent decrease in Vt which 
may help decrease dynamic strain [39].
In our study, a slight but not statistically significant 
decrease in mean arterial pressure was observed. Such 
trend could have been the result of complex interactions 
of PaCO2 and mean airway pressure in cardiovascular 
system.
We think that EIP prolongation is a feasible maneuver 
to optimize the consequences of mechanical ventilation 
in ARDS patients. Physicians may consider using an EIP 
prolongation in the early phase of ARDS when patients 
often require sedation and neuromuscular blocking 
agents. In our study, we have effectively implemented this 
strategy by using active humidification, relatively high 
inspiratory flow rates and close monitoring of PEEPi. 
This bundle decreases PaCO2, which in turn will allow to 
further decrease Vt and the consequent lung strain when 
isocapnic conditions are met.
One of the limitations of our study is the relatively 
small number of patients, the majority with pneumonia, 
and the fact that the study is short term. Studies with 
patients with different ARDS etiologies and larger num-
bers are warranted to confirm our data. Also, we did not 
measure other parameters such as inflammatory media-
tors or lung volumes. The calculation of dead space using 
the Enghoff modification of Bohr equation in patients 
with large shunt fractions (>20–30  %) could underesti-
mate dead space fraction [12]. In our study, we did not 
measure intrapulmonary shunt. However, according to 
the gas exchange values that we obtained, shunt frac-
tions above 30 % are unlikely. Additionally, the EIP pro-
longation increases the mechanical inflation time and it 
could extend into neural expiration. Asynchronies may 
thus develop and cause an inadequate patient–ventilator 
interaction when the patients are not paralyzed [39–41]. 
Our results could be dependent on our routine manage-
ment of mechanical ventilation in ARDS patients, but our 
findings have been consistent in all patients and we con-
sider they could be extrapolated to other ARDS patients. 
Finally, the absolute decrease in tidal volume, although 
statistically significant, is moderate.
Conclusions
In conclusion, our data indicate that EIP prolongation is 
a simple and feasible strategy to decrease dead space and 
PaCO2 levels. In addition, when PaCO2 levels are of no 
clinical concern, EIP prolongation allows us to further 
decrease tidal volume. This, in turn, decreases plateau 
airway pressure, driving airway pressure and improves 
respiratory system compliance, suggesting less overdis-
tension and less risk of dynamic strain and lung injury. 
Therefore, the use of this simple ventilator maneuver 
during mechanical ventilation in sedated and paralyzed 
ARDS patients merits consideration.
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